Evonik cancels June IPO

In Germany, Evonik will likely cancel plans again for an initial public offering in June, says Reuters. The RAG Foundation, co-owners of Evonik, had initially hoped for a valuation at 15b euros in the IPO; they cited insufficient investor support and continued market volatility as reasons for the choice. The IPO would have been the largest in Europe in over a year.

More on the story.